Icon

RUBRAMIN PC (nda006799)- (0.1MG/ML,1MG/ML,1MG/ML)

CYANOCOBALAMIN BRISTOL MYERS SQUIBB
0.1MG/ML,1MG/ML,1MG/ML
No No
Expired Expired
None None
None No
RUBRAMIN PC is indicated for vitamin B12 deficiencies due to malabsorption which may be associated with the following conditions: *Addisonian (pernicious) anemia *Gastrointestinal pathology, dysfunction, or surgery, including gluten enteropathy or sprue, small bowel bacteria overgrowth, total or partial gastrectomy *Fish tapeworm infestation *Malignancy of pancreas or bowel *Folic acid deficiency.
15 0 14
Total Other Developers None
Drugs with Suitability No
0.1MG/ML ** ** - - -
1MG/ML ** ** - - -
NDA Sales Available Total Generic Sales Available
No 13
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****-**** ****** *** ***** ************ (********), *.* *********** ******* *** ** **, */**/**, ******** ******, ****-***, ******** (***) ***
****** ********* **** *** ********* **** ***, *** *********** **** ****** ****, ***** ******, *** **** (**) *****, ****** ****** (***) ***
****** ********* **** *** ********* **** ***, *** *********** **** *. **** ****** **** ***** ********* ******, ******* ****, ******** (**) *****, ****** ****** (***) ***
****** ** ****** ******** ******, ***. *********** * ****** ****, *******, *** **** (**) *****, ****** ****** (***) ***
****** ** ****** ** *********** ** *** *********** ***** **** ** *, ********, ********** (**) *****, ****** ****** (***) ***
****** ***** **** *** ***** ************ ******* *********** (***), **** **. ***-*, *********** ****** **** ****, ********** ****, ****** *****, *********, ********* ******, ***** (***) ***
****** ******** ******* *** ******** ************ ******* ******* *********** **/*, ******** ******* *********** *****, *********, ********* ******, ***** (***) ***
****** ******** ******* *** ***** ****** ******* ******* *********** ** **, ****** ********** *******, ***** *, *****, ********* ******, ***** (***) ***
****** ********* ****** *** ****** ***. *********** **. **, ******* *. **., *****, ******* ******, ****** (***) ***
****** ******** ******* *** ******** ************ ******* ******* *********** **/*, ******** ******* *********** *****, *********, ********* ******, ***** (***) ***
****** ***** ****** ***** ****** ************ ******* *********** ****-***, **** **: *, ** ** **, ***, ** ** **, ****, *****, ***, ************ *******, ********** ******, **********, ********* ******, ***** (***) ***
****** ***** ****** *** ***** ****** ******* *********** **** **: **-**, **, **, **-**, **. **. ***, ***, *** & ***, ***** ***, *****, ************ *******, ********** ******, ********** ********, *********, ********* ******, ***** (***) ***
****** ***** ****** ***** ************ ******* *********** ****** ***. ***/*/* *** ***/*/*, ******** - ***** *******, ******* - *****, ****** - ********, ********, ******* ******, ***** (***) ***
****** ****** ******** ***** *************** ******* *********** **** **. ***/***-****** / **** **.***/****-*********** , *******-***** ******* , ****** -******, ******, *********, ******* ******, ***** (***) ***
****** ****** ******** ***** *************** ******* *********** **** **. * ** **, *******, **** ******* ******, *******-***** *******, **. *-*, ****** ******, *********, ******* ******, ***** (***) ***
****** ******* ****** ******* ****** ******* *********** ****-***, ******* *****, ****** **** ****, ***. ****** *******, ****** *****, *******, ******** ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.